Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [522]
News [1466]
Articles [67]
Editorials [2]
Conferences [72]
elearning [5]
Ipilimumab and BRAF inhibitors for advanced melanoma
Dr Lynn Schuchter - University of Pennsylvania, USA
Ipilimumab and BRAF inhibitors for advanced melanoma ( Dr Lynn Schuchter - University of Pennsylvania, USA )
2 Jun 2013
PDL1 inhibitors in melanoma
Dr Roy Herbst - Yale Cancer Center, New Haven, USA
PDL1 inhibitors in melanoma ( Dr Roy Herbst - Yale Cancer Center, New Haven, USA )
2 Jun 2013
Comment on drug developments in advanced melanoma
Dr Roy Herbst - Yale Cancer Center, New Haven, USA
Comment on drug developments in advanced melanoma ( Dr Roy Herbst - Yale Cancer Center, New Haven, USA )
2 Jun 2013
Nivolumab produces long-lasting responses in patients with stage IV melanoma
Dr Mario Sznol - Yale Cancer Center, New Haven, USA
Nivolumab produces long-lasting responses in patients with stage IV melanoma ( Dr Mario Sznol - Yale Cancer Center, New Haven, USA )
1 Jun 2013
New MEK inhibitor selumetinib is the first effective drug for advanced melanoma...
Dr Richard D. Carvajal - Memorial Sloan-Kettering Cancer Center, New York, USA
New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye ( Dr Richard D. Carvajal - Memorial Sloan-Kettering Cancer Center, New York, USA )
1 Jun 2013
Anti-PD-1 drug nivolumab shows high and durable clinical activity in patients...
Dr Mario Sznol - Yale Cancer Center New Haven, USA
Anti-PD-1 drug nivolumab shows high and durable clinical activity in patients with advanced melanoma ( Dr Mario Sznol - Yale Cancer Center New Haven, USA )
1 Jun 2013
Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone
Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2013
Prevention of squamous cell carcinoma
Dr Kenneth Tsai - MD Anderson Cancer Center, Houston, USA
Prevention of squamous cell carcinoma ( Dr Kenneth Tsai - MD Anderson Cancer Center, Houston, USA )
23 Apr 2013
Immunotherapy in melanoma and other cancers
Dr Suzanne Topalian – Johns Hopkins, Baltimore, USA
Immunotherapy in melanoma and other cancers ( Dr Suzanne Topalian – Johns Hopkins, Baltimore, USA )
19 Apr 2013
Intermittent treatment with vemurafenib may prevent lethal drug resistance in...
Dr Darrin Stuart - Novartis Institutes for Biomedical Research, Emeryville, CA...
Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma ( Dr Darrin Stuart - Novartis Institutes for Biomedical Research, Emeryville, CA, USA )
8 Apr 2013
History of epidermal stem cell use in the clinical setting
Prof Michele De Luca - University of Modena e Reggio Emilia, Modena, Italy
History of epidermal stem cell use in the clinical setting ( Prof Michele De Luca - University of Modena e Reggio Emilia, Modena, Italy )
14 Dec 2012
Analysing the efficacy of treatment through Response Evaluation Criteria in...
Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation